Ovarian Cancer Prevention Clinical Trial
Official title:
Opportunistic Salpingectomy in Non-gynecological Surgeries - a Pilot Study
| Verified date | September 2023 |
| Source | Meir Medical Center |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this study is to evaluate patient's compliance for opportunistic salpingectomy (OS) and procedure feasibility in non gynecological abdominal surgeries
| Status | Completed |
| Enrollment | 42 |
| Est. completion date | February 28, 2023 |
| Est. primary completion date | December 31, 2022 |
| Accepts healthy volunteers | No |
| Gender | Female |
| Age group | 40 Years and older |
| Eligibility | Inclusion Criteria: - Women who were candidates for non-gynecological abdominal surgery - Aged 45 or older, or aged 40 or older with a desire for bilateral salpingectomy Exclusion Criteria: - Pregnant women - Candidates for urgent surgery |
| Country | Name | City | State |
|---|---|---|---|
| Israel | Meir medical center | Kfar Saba |
| Lead Sponsor | Collaborator |
|---|---|
| Dana Josephy |
Israel,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | patients willing for salpingectomy | The number of patients that will agree for salpingectomy | day of enrollment | |
| Primary | patients undergoing salpingectomy | The number of patients that will undergo salpingectomy | from enrollment and up to 6 weeks | |
| Primary | length of salpingectomy | the length (in minutes) of salpingectomy | within surgery | |
| Primary | surgical complications | complications during or after salpingectomy | up to 30 days from surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03480776 -
ASA in Prevention of Ovarian Cancer (STICs and STONEs)
|
Phase 2 |